AN2 Therapeutics, Inc.ANTXNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | -0 | 0 | 0 |
| Operating Income | -7 | -22↓196.2% | -42↓95.9% | -70↓64.8% | -55↑21.7% |
| Net Income | -14 | -22↓58.4% | -41↓90.1% | -65↓58.1% | -51↑20.7% |
| EBITDA | -6 | -22↓241.4% | -41↓89.5% | 5↑112.0% | 3↓34.1% |
| EPS Diluted | -0.78 | -1.50↓92.3% | -2.79↓86.0% | -2.74↑1.8% | -1.72↑37.2% |